What does PI stand for?

Protease Inhibitor

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Program Interruption Program Isolation (IBM) Programmed Instruction Project Identification (number) Projector Infantry Projets Individuels Propidium Iodide Proportional-Integral (controller) Propriedade Intelectual (Intellectual Property, Brazil) Prospective Internationale		Proto-I.jo Protocol Interpreter Provider Independent (IP address space assigned by IANA) Proyectos Industriales Psicología Integrada (Portugese) Psykoterapiinstitut (Stockholm, Sweden) Public Information Public Intoxication (law enforcement) Pulmonary Infection (lungs) Pulsatility Index

Samples in periodicals archive:

The team then used a specific small-molecule protease inhibitor of calpain in these mice.

Missing protein in rare genetic brain disorder restored

Aptivus is a protease inhibitor, a class of HIV drugs that interfere with virus replication, the German drug maker said in a statement.

Europe: Boehringer Ingelheim wins European approval for HIV drug ...

The drug, also known as darunavir, is a member of the protease inhibitor class of drugs.

FDA Approves New Drug to Treat HIV

It has been almost 10 years since the approval of the first protease inhibitor (Invirase) in December 1995.

Therapeutic and diagnostic advances in the HAART era

Chiron Corporation, Emeryville, CA, and Enanta Pharmaceuticals, Watertown, MA, announced the companies have signed an exclusive agreement to develop and commercialize Chiron's portfolio of hepatitis C virus (HCV) protease inhibitors.

Chiron, Enanta Pharmaceuticals sign agreement for developing, ...

Tipranavir: This protease inhibitor is widely believed to be the next HIV med to be approved by the Food and Drug Administration (FDA).

Tipranavir

Richard Haubrich of the University of California, San Diego and his colleagues gave various doses of TMC114 to almost 400 people for whom a different protease inhibitor was failing to control HIV.

New protease inhibitor looks promising

1) Furthermore, women who take protease inhibitors as part of their combined drug regimen are no more likely to have a premature or very premature delivery or a low-birth-weight infant than are women who use combination therapy without these drugs, monotherapy or no therapy.

Use of multiple anti-HIV drugs does not raise risk of adverse birth ...